Poltreg (WAR:PTG) Other Stockholders Equity: zł113.35 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:PTG Poltreg SA WAR:PTG
46 GF Score
Price zł23.10
GF Value zł14.20
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Poltreg Other Stockholders Equity?

Poltreg WAR:PTG +1.76% 46 Other Stockholders Equity is zł113.35 Mil as of Mar. 2026. GuruFocus rates WAR:PTG with a GF Score™ of 46/100 and a GF Value™ of zł14.20 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Poltreg's Other Stockholders Equity for the quarter that ended in Mar. 2026 was zł113.35 Mil.

Poltreg's quarterly Other Stockholders Equity declined from Sep. 2025 (zł113.46 Mil) to Dec. 2025 (zł113.28 Mil) but then increased from Dec. 2025 (zł113.28 Mil) to Mar. 2026 (zł113.35 Mil).

Poltreg's annual Other Stockholders Equity increased from Dec. 2023 (zł112.76 Mil) to Dec. 2024 (zł113.18 Mil) and increased from Dec. 2024 (zł113.18 Mil) to Dec. 2025 (zł113.28 Mil).

Poltreg Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Poltreg's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Poltreg Other Stockholders Equity Chart

Poltreg Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 112.73 112.73 112.76 113.18 113.28

Poltreg Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 113.28 113.37 113.46 113.28 113.35
WAR:PTG
46GF Score
Poltreg SA WAR:PTG
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Poltreg Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of zł113.35 Mil mean?
Poltreg (WAR:PTG) has a Other Stockholders Equity of zł113.35 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Poltreg and its competitors.
Is Poltreg's Other Stockholders Equity too high?
Poltreg's current Other Stockholders Equity is zł113.35 Mil. Overall, Poltreg has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Poltreg's Other Stockholders Equity compare to VRTX and REGN?
Poltreg's Other Stockholders Equity of zł113.35 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Poltreg and its competitors. Poltreg's current Other Stockholders Equity is zł113.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Poltreg stock overvalued right now?
Based on GuruFocus' analysis, Poltreg (WAR:PTG) is currently considered Significantly Overvalued. The stock's GF Value™ is zł14.20, compared to a current price of zł23.10 — trading 62.7% above its estimated fair value. The current Other Stockholders Equity is zł113.35 Mil. Poltreg's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Poltreg (WAR:PTG), the current Other Stockholders Equity is zł113.35 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Poltreg (WAR:PTG) Overvalued in 2026?

Based on GuruFocus' analysis, Poltreg stock appears to be overvalued. The current stock price of zł23.10 is trading 62.7% above its estimated GF Value™ of zł14.20. GuruFocus considers Poltreg to be Significantly Overvalued.

Key valuation signals for WAR:PTG:

  • Other Stockholders Equity: zł113.35 Mil
  • GF Value™: zł14.20 vs. price of zł23.10 (62.7% above fair value)
  • GF Score™: 46/100 with 3 warning signs

No single metric tells the full story. See the WAR:PTG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Poltreg Business Description

Address ul.Botaniczna 20, Gdansk, POL, 80-298
Poltreg SA is a biotechnology company at the clinical stage developing an innovative generation of medicines using T-regulatory cells (TREGS) in the treatment of autoimmune diseases.
46GF Score

Get the complete analysis for WAR:PTG

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł23.10
Price
zł14.20
GF Value